#United States #New York #B. Riley Securities #Oncology Conference #Radiopharma

B. Riley Securities to Host Precision Oncology & Radiopharma Investor Conference

B. Riley Securities, Inc., a leading middle market investment bank, is set to host its much-anticipated Precision Oncology & Radiopharma Investor Conference in New York City on February 28, 2025. The event promises to be a significant gathering for industry experts, featuring over 30 leading companies that are at the forefront of developing and commercializing innovative oncology and radiopharmaceutical approaches.

The conference will span one full day and aims to provide a unique platform for investors to hear from executives and analysts about recent advancements and future trends in this rapidly evolving sector. Attendees can expect comprehensive discussions led by B. Riley's Equity Research Analysts, covering notable themes such as:

• - Recent disruptions in healthcare policy
• - The evolving radiopharma value chain
• - Developments in antibody drug conjugates and T-cell engagers
• - Novel synthetic lethality approaches

As the field of oncology and radiopharmaceuticals expands, the participating companies have played an influential role in recent acquisitions within the pharmaceutical landscape. The conference aims to shed light on breakthrough therapies and the potential investment opportunities they bring.

Andy Moore, the CEO of B. Riley Securities, expressed excitement about hosting this conference, stating, "We are thrilled to gather a select group of pioneering companies that are leading the charge in life-saving therapeutic and imaging innovations. Their vital work presents an incredible opportunity for investors to engage with the next tier of advancements in healthcare."

The schedule for the event is robust, featuring a variety of formats including research analyst-moderated panels, insightful presentations, interactive fireside chats, and collaborative roundtable discussions. However, attendance is by invitation only, highlighting the exclusivity and importance of the event.

For those interested in attending, the organizers have opened registrations via email at [email protected]. This gathering is expected to attract a diverse range of investors looking to gain insights into the cutting-edge advancements in oncology and radiopharmaceuticals.

B. Riley Securities has been a notable player in the investment banking landscape for over 25 years, recognized for its comprehensive suite of services including initial public offerings, institutional private placements, and M&A advisory. The firm emphasizes its thematic proprietary equity research, enabling clients to leverage its vast network and industry expertise.

For additional information about B. Riley Securities and the upcoming conference, please visit www.brileysecurities.com.

Overall, the Precision Oncology & Radiopharma Investor Conference is positioned to be a pivotal event that will shape discussions and future investments in the field, providing attendees with critical insights and networking opportunities as the industry continues to evolve.